Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
Launched by ZS ASSOCIATES · Mar 4, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help identify people who may have a condition called myasthenia gravis (MG), which affects the nerves and muscles. The researchers are using a social media campaign to reach adults in the U.S. who have unexplained muscle weakness or other symptoms that could suggest MG. Participants will complete a self-assessment tool online to see if their symptoms match those of MG. The goal is to encourage those who may have undiagnosed MG to seek medical evaluation and receive appropriate care.
To be eligible for this trial, participants need to be at least 18 years old (or older, depending on their state) and live in one of the 50 states in the U.S. They should also have an active email account and be able to read and understand English. However, people who have already been diagnosed with MG or certain other conditions, like multiple sclerosis, cannot participate. This study is fully remote, so participants can take part from the comfort of their own home, making it easier for those who might find it challenging to visit a clinic in person.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Reside within the 50 states of the United States at the time of enrollment
- • Age 19 or older if reside in Nebraska or Alabama, Age 21 or older if reside in Mississippi, Age 18 years or older if reside in any other state
- • Active email account
- • Fluency in English (spoken / written), as demonstrated by the ability to read and sign the Informed Consent Form
- Exclusion Criteria:
- • Live in an overseas territory of the United States
- • Inability or unwillingness to provide written informed consent
- • Diagnosed myasthenia gravis, including sero-negative MG\*
- • Diagnosed multiple sclerosis
- • Have speech impairment, eye/arm/leg weakness due to diagnosed brain cancer, or stroke
About Zs Associates
ZS Associates is a global consulting and technology firm specializing in transforming healthcare through data-driven insights and innovative solutions. With a strong focus on clinical trial optimization and life sciences, ZS leverages its extensive expertise in analytics, strategy, and operational execution to enhance the efficiency and effectiveness of clinical research. The firm collaborates with pharmaceutical, biotech, and medical device companies to streamline trial processes, improve patient engagement, and ensure regulatory compliance, ultimately driving better outcomes in drug development and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Evanston, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported